Halopemide

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Halopemide 是一种有效的 PLD 抑制剂（对于人 PLD1 和 PLD2，IC50 = 220 和 310 nM）。 Halopemid 是多巴胺受体拮抗剂。氟哌米特可用于精神治疗研究。

Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.(In Vitro):In transdifferentiated MOVAS cells, Halopemide (1-2 μM; 21 days) influences calcification.(In Vivo):In the majority of monkeys tested, Halopemide (10 mg/kg; p.o.) causes dyskinesias.

Halopemide (1-2 μM; 21 day) affects calcification in transdifferentiated MOVAS cells.

Halopemide (10 mg/kg; p.o.) induces dyskinesias in the majority of monkeys tested.

——

Others

Other Targets

CDK9

——

——

59831-65-1

416.88

C21H22ClFN4O2

>98% (HPLC)

In Vitro:?DMSO : 41.67 mg/mL (99.96 mM)

Fc1ccc(cc1)C(=O)NCCN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O

——

(-20℃)

With Ice Pack

≥ 2 years